These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 33807268)

  • 21. COVID-19 Risk Assessment for the Tokyo Olympic Games.
    Zhu W; Feng J; Li C; Wang H; Zhong Y; Zhou L; Zhang X; Zhang T
    Front Public Health; 2021; 9():730611. PubMed ID: 34760863
    [No Abstract]   [Full Text] [Related]  

  • 22. Incidence and burden of illness at the Tokyo 2020 Paralympic Games held during the COVID-19 pandemic: a prospective cohort study of 66 045 athlete days.
    Derman W; Runciman P; Eken M; Boer PH; Blauwet C; Bogdos M; Idrisova G; Jordaan E; Kissick J; LeVan P; Lexell J; Mohammadi F; Patricio M; Schwellnus M; Webborn N; Willick SE; Yagishita K
    Br J Sports Med; 2022 Dec; ():. PubMed ID: 36588431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FIFA World Cup 2022: What can we learn from the inspiring Tokyo 2020 Olympic Games held in COVID-19 times?
    Dergaa I; Musa S; Romdhani M; Souissi A; Abdulmalik MA; Chamari K; Saad HB
    Biol Sport; 2022 Oct; 39(4):1073-1080. PubMed ID: 36247947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute in-competition medical care at the Tokyo 2020 Olympics: a retrospective analysis.
    Tanaka H; Tanaka S; Yokota H; Otomo Y; Masuno T; Nakano K; Sugita M; Tokunaga T; Sugimoto K; Inoue J; Kato N; Kinoshi T; Sakanashi S; Inoue H; Numata H; Nakagawa K; Miyamoto T; Akama T
    Br J Sports Med; 2023 Nov; 57(21):1361-1370. PubMed ID: 37055080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Understanding COVID-19: A Hybrid Threat and Its Impact on Sport Mega-Events. A Focus on Japan and the Tokyo 2020 Olympic Games.
    Ilevbare SI; McPherson G
    Front Sports Act Living; 2022; 4():720591. PubMed ID: 35274095
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of the Tokyo 2020 Summer Olympic Games on COVID-19 incidence in Japan: a synthetic control approach.
    Yoneoka D; Eguchi A; Fukumoto K; Kawashima T; Tanoue Y; Tabuchi T; Miyata H; Ghaznavi C; Shibuya K; Nomura S
    BMJ Open; 2022 Sep; 12(9):e061444. PubMed ID: 36127076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. COVID-19 risk assessment at the opening ceremony of the Tokyo 2020 Olympic Games.
    Murakami M; Miura F; Kitajima M; Fujii K; Yasutaka T; Iwasaki Y; Ono K; Shimazu Y; Sorano S; Okuda T; Ozaki A; Katayama K; Nishikawa Y; Kobashi Y; Sawano T; Abe T; Saito MM; Tsubokura M; Naito W; Imoto S
    Microb Risk Anal; 2021 Dec; 19():100162. PubMed ID: 33778137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Did the Tokyo Olympic Games enhance the transmission of COVID-19? An interpretation with machine learning.
    Hirata A; Kodera S; Diao Y; Rashed EA
    Comput Biol Med; 2022 Jul; 146():105548. PubMed ID: 35537221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trends in emergency transportation due to heat illness under the new normal lifestyle in the COVID-19 era, in Japan and 47 prefectures.
    Uryu S; Tanoue Y; Nomura S; Matsuura K; Makiyama K; Kawashima T; Yoneoka D; Eguchi A; Kawamura Y; Gilmour S; Sakamoto H; Shimizu K; Ng CFS; Hashizume M
    Sci Total Environ; 2021 May; 768():144723. PubMed ID: 33454494
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What has the 2020 Tokyo Olympic and Paralympic Games taught global health on sporting mass gatherings under COVID-19 pandemic?
    Shimizu K; Mossialos E; Shibuya K
    Anaesth Crit Care Pain Med; 2022 Feb; 41(1):101001. PubMed ID: 34902633
    [No Abstract]   [Full Text] [Related]  

  • 31. Baseline scenarios of heat-related ambulance transportations under climate change in Tokyo, Japan.
    Fujimoto M; Nishiura H
    PeerJ; 2022; 10():e13838. PubMed ID: 35923895
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Chaotic Behavior of the Spread of Infection during the COVID-19 Pandemic in Japan.
    Sapkota N; Murata A; Karwowski W; Davahli MR; Fiok K; Aljuaid AM; Marek T; Ahram T
    Int J Environ Res Public Health; 2022 Oct; 19(19):. PubMed ID: 36232099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SARS-CoV-2 Infections in Close Contacts of Positive Cases in the Olympic and Paralympic Village at the 2021 Tokyo Olympic and Paralympic Games.
    Akashi H; Shimada S; Tamura T; Chinda E; Kokudo N
    JAMA; 2022 Mar; 327(10):978-980. PubMed ID: 35113161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predicted dominance of variant Delta of SARS-CoV-2 before Tokyo Olympic Games, Japan, July 2021.
    Ito K; Piantham C; Nishiura H
    Euro Surveill; 2021 Jul; 26(27):. PubMed ID: 34240695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emergency department activities at the Athletes' Village during the Tokyo 2020 Olympic and Paralympic Games.
    Kuroki N; Yagishita K; Shimizu K; Okuaki S; Doi Y; Arakawa Y; Nakano T; Akama T
    Acute Med Surg; 2023; 10(1):e905. PubMed ID: 38020491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cross-Border Transmissions of the Delta Substrain AY.29 During Tokyo Olympic and Paralympic Games.
    Koyama T; Tokumasu R; Katayama K; Saito A; Kudo M; Imoto S
    Front Microbiol; 2022; 13():883849. PubMed ID: 35992703
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence of staff injury and illness at the Tokyo 2020 and Beijing 2022 Olympic and Paralympic Games.
    Larson EG; Hasley I; Post EG; Cali MG; Clark SC; McPherson AL; Noble-Taylor KE; Robinson DM; Anderson T; Finnoff J; Adams WM
    BMJ Open Sport Exerc Med; 2024; 10(2):e001835. PubMed ID: 38645762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of SARS-CoV-2 Load in Wastewater With Reported COVID-19 Cases in the Tokyo 2020 Olympic and Paralympic Village From July to September 2021.
    Kitajima M; Murakami M; Kadoya SS; Ando H; Kuroita T; Katayama H; Imoto S
    JAMA Netw Open; 2022 Aug; 5(8):e2226822. PubMed ID: 35994292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Tokyo 2020 Olympic and Paralympic pharmacy services during the COVID-19 pandemic.
    Kasashi K; Sato A; Stuart M; Hollywood Ú; Kawaguchi-Suzuki M; Yagishita K; Akama T
    J Am Pharm Assoc (2003); 2023; 63(4):1156-1161. PubMed ID: 36965764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resurgence of Respiratory Syncytial Virus Infections during COVID-19 Pandemic, Tokyo, Japan.
    Ujiie M; Tsuzuki S; Nakamoto T; Iwamoto N
    Emerg Infect Dis; 2021 Nov; 27(11):2969-2970. PubMed ID: 34388086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.